B Långström Selected Research

B Långström Research Topics

Disease

9	Neoplasms (Cancer) 07/2007 - 01/2000
6	Carcinoid Tumor (Carcinoid) 01/2006 - 01/2000
5	Alzheimer Disease (Alzheimer's Disease) 02/2010 - 02/2006
2	Parkinson Disease (Parkinson's Disease) 01/2008 - 03/2001
2	Lymphatic Metastasis 03/2000 - 01/2000
1	Social Phobia 07/2015
1	Pathologic Processes 02/2010
1	Cognitive Dysfunction 02/2010
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2003
1	Stroke (Strokes) 10/2001
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2001
1	Glioma (Gliomas) 09/2001
1	Oligodendroglioma 09/2001
1	Wounds and Injuries (Trauma) 08/2001
1	Meningioma (Meningiomas) 08/2001
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2001
1	Ischemia 07/2001
1	Partial Epilepsies (Epilepsy, Partial) 06/2001
1	Schizophrenia (Dementia Praecox) 04/2001
1	Brain Neoplasms (Brain Tumor) 01/2001
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 07/2000
1	Joint Diseases (Joint Disease) 07/2000
1	Alcoholic Hepatitis 07/2000
1	Fatty Liver 07/2000
1	Liver Diseases (Liver Disease) 07/2000
1	Neuroblastoma 01/2000

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 02/2010 - 03/2000
3	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 06/2005 - 01/2000
2	Amyloid beta-PeptidesIBA 02/2010 - 01/2008
2	Amyloid (Amyloid Fibrils)IBA 02/2010 - 01/2008
2	AcetylcholinesteraseIBA 08/2008 - 02/2008
2	Galantamine (Galanthamine)FDA LinkGeneric 08/2008 - 02/2008
2	RadiopharmaceuticalsIBA 07/2007 - 06/2005
2	Carbidopa (Lodosyn)FDA LinkGeneric 01/2006 - 03/2000
2	metomidateIBA 06/2005 - 02/2000
2	Monoamine Oxidase (MAO)IBA 08/2003 - 04/2003
2	Serotonin (5 Hydroxytryptamine)IBA 08/2003 - 03/2000
2	Methionine (L-Methionine)FDA Link 09/2001 - 08/2001
2	Glutamic Acid (Glutamate)FDA Link 07/2001 - 01/2000
1	vofopitantIBA 07/2015
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2008
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2008
1	alpha-SynucleinIBA 01/2008
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2006
1	Rivastigmine (Exelon)FDA LinkGeneric 02/2006
1	Dihydroxyphenylalanine (Dopa)IBA 06/2005
1	Dopamine (Intropin)FDA LinkGeneric 08/2003
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2003
1	Glycerol (Glycerine)FDA LinkGeneric 10/2001
1	Indicators and Reagents (Reagents)IBA 09/2001
1	Flumazenil (Romazicon)FDA LinkGeneric 08/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	Oxygen (Dioxygen)IBA 07/2001
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2001
1	Quetiapine Fumarate (Seroquel)FDA Link 04/2001
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2001
1	Hyaluronic Acid (Hyaluronan)IBA 07/2000
1	Radioisotopes (Radionuclides)IBA 07/2000
1	EnzymesIBA 03/2000
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2000
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2000
1	Carboxy-LyasesIBA 03/2000
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2000
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2000
1	Levodopa (L Dopa)FDA LinkGeneric 03/2000
1	Proteins (Proteins, Gene)FDA Link 03/2000
1	Peptides (Polypeptides)IBA 03/2000
1	Cystine (L-Cystine)IBA 01/2000
1	Aspartic Acid (Aspartate)FDA Link 01/2000
1	Amino Acids FDA Link 01/2000
1	Glutamine (L-Glutamine)FDA Link 01/2000

Therapy/Procedure

1	Oral Administration 01/2006
1	Premedication 03/2000